Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer.


Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
19 09 2022
Historique:
received: 23 02 2022
accepted: 08 09 2022
entrez: 19 9 2022
pubmed: 20 9 2022
medline: 23 9 2022
Statut: epublish

Résumé

Lung cancer patients are diagnosed at late stages when curative treatments are no longer possible; thus, molecular biomarkers for noninvasive detection are urgently needed. In this sense, we previously identified and validated an epigenetic 4-gene signature that yielded a high diagnostic performance in tissue and invasive pulmonary fluids. We analyzed DNA methylation levels using the ultrasensitive digital droplet PCR in noninvasive samples in a cohort of 83 patients. We demonstrated that BCAT1 is the candidate that achieves high diagnostic efficacy in circulating DNA derived from plasma (area under the curve: 0.85). Impact of potentially confounding variables was also explored.

Identifiants

pubmed: 36123616
doi: 10.1186/s13148-022-01334-3
pii: 10.1186/s13148-022-01334-3
pmc: PMC9487112
doi:

Substances chimiques

Biomarkers, Tumor 0
Cell-Free Nucleic Acids 0
DNA 9007-49-2
BCAT1 protein, human EC 2.6.1.
Transaminases EC 2.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116

Informations de copyright

© 2022. The Author(s).

Références

J Thorac Oncol. 2011 Oct;6(10):1632-8
pubmed: 21694641
Cancers (Basel). 2021 Jun 16;13(12):
pubmed: 34208598
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Circ Cardiovasc Genet. 2016 Oct;9(5):436-447
pubmed: 27651444
Clin Cancer Res. 2017 Nov 15;23(22):7141-7152
pubmed: 28855354
Clin Cancer Res. 2016 Jul 1;22(13):3361-71
pubmed: 26842235
Clin Cancer Res. 2020 Aug 15;26(16):4339-4348
pubmed: 32430478
Nat Commun. 2020 Jul 21;11(1):3475
pubmed: 32694610
J Thorac Oncol. 2019 Mar;14(3):343-357
pubmed: 30529598
J Thorac Oncol. 2017 Jan;12(1):77-84
pubmed: 27544059
Lung Cancer. 2013 Sep;81(3):397-403
pubmed: 23806794
Nat Rev Genet. 2019 Feb;20(2):109-127
pubmed: 30479381
BMC Cancer. 2010 Nov 03;10:600
pubmed: 21047392

Auteurs

Cora Palanca-Ballester (C)

Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026, Valencia, Spain.

David Hervas (D)

Department of Applied Statistics and Operational Research and Quality, Universitat Politècnica de València, Valencia, Spain.

Maria Villalba (M)

CIBERONC, ISCIII, 28029, Madrid, Spain.
IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.

Teresa Valdes-Sanchez (T)

BEMYGENE, Parc Científic University of Valencia, Paterna, Spain.

Diana Garcia (D)

Epigenomics Unit, Health Research Institute La Fe, Valencia, Spain.

Maria Isabel Alcoriza-Balaguer (MI)

Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026, Valencia, Spain.

Marta Benet (M)

Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026, Valencia, Spain.

Raquel Martinez-Tomas (R)

Pneumology Service, University Hospital La Fe, Valencia, Spain.

Andres Briones-Gomez (A)

Pneumology Service, University Hospital La Fe, Valencia, Spain.

Jose Galbis-Caravajal (J)

Thoracic Surgery Service, University Hospital La Ribera, Alzira, Spain.

Alfonso Calvo (A)

CIBERONC, ISCIII, 28029, Madrid, Spain.
IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.

Oscar Juan (O)

Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026, Valencia, Spain.

Agustin Lahoz (A)

Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026, Valencia, Spain.

Enrique Cases (E)

Pneumology Service, University Hospital La Fe, Valencia, Spain.

Juan Sandoval (J)

Biomarkers and Precision Medicine Unit, Health Research Institute La Fe, Av. Fernando Abril Martorell, 106, 46026, Valencia, Spain. epigenomica@iislafe.es.
Epigenomics Unit, Health Research Institute La Fe, Valencia, Spain. epigenomica@iislafe.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH